Showing 31 - 40 of 395,341
Persistent link: https://www.econbiz.de/10003501693
Persistent link: https://www.econbiz.de/10003512842
Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...
Persistent link: https://www.econbiz.de/10009492625
Social insurance programs typically comprise sick leave insurance. An important policy parameter is how the cost of sick leave are shared between workers, firms, and the social security system. We show that this sharing rule affects not only absence behavior, but also workers' subsequent health....
Persistent link: https://www.econbiz.de/10010532515
Social insurance programs typically comprise sick leave insurance. An important policy parameter is how the cost of sick leave are shared between workers, firms, and the social security system. We show that this sharing rule affects not only absence behavior, but also workers' subsequent health....
Persistent link: https://www.econbiz.de/10011284261
This paper studies interaction of pharmaceutical regulation and parallel trade in a North-South framework. An … South being larger if both countries regulate as compared to only the South limiting reimbursement. Stricter regulation, i …
Persistent link: https://www.econbiz.de/10011290061
Persistent link: https://www.econbiz.de/10011378658
Persistent link: https://www.econbiz.de/10009751214
Persistent link: https://www.econbiz.de/10009733034
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10010224844